CANCER

Anonymous

Guest
".....at the European conference that adds a wrinkle to the success of existing medicines such as Byetta and Victoza and may raise concerns about Bydureon. Some researchers believe the class of drugs to which these products belong may increase the risk of cancer."
Comments? What have you herd?
 






".....at the European conference that adds a wrinkle to the success of existing medicines such as Byetta and Victoza and may raise concerns about Bydureon. Some researchers believe the class of drugs to which these products belong may increase the risk of cancer."
Comments? What have you herd?

I haven't "herd" anything butthead.
 






"...Byetta and Victoza, will be a highlight of the European Association for the Study of Diabetes conference in Lisbon this week. A review of a database of side effects showed patients taking Byetta and a Merck & Co. drug had a sixfold increased chance of pancreatitis, which in turn raises the risk of tumors, researchers led by Robert Elashoff of the University of California at Los Angeles said this year."